Literature DB >> 27252352

Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum.

Noemí Santana1,2, Francesc Artigas1,2,3.   

Abstract

The prefrontal cortex (PFC) is enriched in several serotonin receptors, including 5-HT1A-R, 5-HT2A-R, and 5-HT3-R. These receptors modulate PFC activity due to their expression in large neuronal populations (5-HT1A-R, 5-HT2A-R) or in selected GABAergic populations (5-HT3-R). They are also relevant for antidepressant and antipsychotic drug action. Less is known about the localization of 5-HT2C-R, for which atypical antipsychotics show high affinity. Here, we report on the cellular distribution of 5-HT2C-R in rat PFC and striatum, using double in situ hybridization histochemistry. In PFC, 5-HT2C-R are expressed in pyramidal (VGLUT1-positive) and GABAergic (GAD-positive) neurons, including parvalbumin-positive neurons. There is a marked dorso-ventral gradient in the proportion of VGLUT1-positive cells expressing 5-HT2C-R (9% in the cingulate cortex, 61% in the tenia tecta and 66% in the piriform cortex), less marked for GABAergic neurons (13-27%). There is also a laminar gradient, with more cells expressing 5-HT2C-R in deep (V-VI) than in intermediate (II-III) layers. In common with 5-HT3-R, layer I GABAergic cells express 5-HT2C-R. The proportion of 5-HT2C-R-expressing striatal neurons was 23% (dorsolateral caudate-putamen), 37% (ventromedial caudate-putamen), 53% (nucleus accumbens-core), and 49% (nucleus accumbens-shell). These results help to better understand the serotonergic modulation of PFC-based networks, including basal ganglia circuits, and atypical antipsychotic drug action.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  5-HT2C receptors; GABA interneurons; atypical antipsychotic drugs; prefrontal cortex; pyramidal neurons

Mesh:

Substances:

Year:  2017        PMID: 27252352     DOI: 10.1093/cercor/bhw148

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  9 in total

Review 1.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

2.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

3.  Serotonergic afferents from the dorsal raphe decrease the excitability of pyramidal neurons in the anterior piriform cortex.

Authors:  Dejuan Wang; Xiaojie Wang; Penglai Liu; Siqi Jing; Han Du; Lingzhi Zhang; Fan Jia; Anan Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-28       Impact factor: 11.205

4.  Age- and sex-dependent effects of methamphetamine on cognitive flexibility and 5-HT2C receptor localization in the orbitofrontal cortex of Sprague-Dawley rats.

Authors:  Emily R Hankosky; Sara R Westbrook; Rachel M Haake; Jari Willing; Lori T Raetzman; Janice M Juraska; Joshua M Gulley
Journal:  Behav Brain Res       Date:  2018-04-30       Impact factor: 3.332

Review 5.  The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.

Authors:  Clinton E Canal; Kevin S Murnane
Journal:  J Psychopharmacol       Date:  2016-11-15       Impact factor: 4.153

Review 6.  Laminar and Cellular Distribution of Monoamine Receptors in Rat Medial Prefrontal Cortex.

Authors:  Noemí Santana; Francesc Artigas
Journal:  Front Neuroanat       Date:  2017-09-28       Impact factor: 3.856

7.  Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.

Authors:  Rubén Pavia-Collado; Raquel Rodríguez-Aller; Diana Alarcón-Arís; Lluís Miquel-Rio; Esther Ruiz-Bronchal; Verónica Paz; Leticia Campa; Mireia Galofré; Véronique Sgambato; Analia Bortolozzi
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

Review 8.  Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action.

Authors:  Mark J Millan
Journal:  Ther Adv Psychopharmacol       Date:  2022-06-30

9.  Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.

Authors:  Monika Herian; Adam Wojtas; Małgorzata Katarzyna Sobocińska; Mateusz Skawski; Alejandro González-Marín; Krystyna Gołembiowska
Journal:  Pharmacol Rep       Date:  2020-11-10       Impact factor: 3.024

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.